Cargando…

Neutralizing Antibodies and Antibody-Dependent Enhancement in COVID-19: A Perspective

Antibody-dependent enhancement (ADE) is an alternative route of viral entry in the susceptible host cell. In this process, antiviral antibodies enhance the entry access of virus in the cells via interaction with the complement or Fc receptors leading to the worsening of infection. SARS-CoV-2 variant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ajmeriya, Swati, Kumar, Amit, Karmakar, Subhradip, Rana, Shweta, Singh, Harpreet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814804/ https://www.ncbi.nlm.nih.gov/pubmed/35136306 http://dx.doi.org/10.1007/s41745-021-00268-8

Ejemplares similares

Neutralizing Antibody Therapeutics for COVID-19
por: Hurt, Aeron C., et al.
Publicado: (2021)

Neutralizing antibody: a savior in the Covid-19 disease
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

Tackling COVID-19 with neutralizing monoclonal antibodies
por: Corti, Davide, et al.
Publicado: (2021)

Overview of Neutralizing Antibodies and Their Potential in COVID-19
por: Morales-Núñez, José Javier, et al.
Publicado: (2021)

Neutralizing monoclonal antibodies for treatment of COVID-19
por: Taylor, Peter C., et al.
Publicado: (2021)

Neutralizing antibodies for the prevention and treatment of COVID-19
por: Du, Lanying, et al.
Publicado: (2021)

Fault Lines in India’s COVID-19 Management: Lessons Learned and Future Recommendations
por: Dhar, Ruby, et al.
Publicado: (2021)

VACCINE-INDUCED ANTIBODY DEPENDENT ENHANCEMENT IN COVID-19
por: SRIDHAR, PRIYANKA, et al.
Publicado: (2022)

Neutralizing monoclonal antibodies for COVID-19 treatment and prevention
por: Jaworski, Juan Pablo
Publicado: (2021)

Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement
por: Sarker, Animesh, et al.
Publicado: (2023)

Antibody and complement-dependent viral neutralization
por: Cooper, Neil R., et al.
Publicado: (1979)

Antibody-Dependent Enhancement and the Critical Pattern of COVID-19: Possibilities and Considerations
por: Farshadpour, Fatemeh, et al.
Publicado: (2021)

Antibody-dependent enhancement of coronavirus
por: Wen, Jieqi, et al.
Publicado: (2020)

Neutralizing antibody response in mild COVID-19
por: van der Heide, Verena
Publicado: (2020)

COVID-19 reinfection in the presence of neutralizing antibodies
por: Zhang, Ju, et al.
Publicado: (2021)

Tackling COVID-19 with neutralizing monoclonal antibodies
por: Corti, Davide, et al.
Publicado: (2021)

Broadly neutralizing antibodies against COVID-19
por: Zhou, Daming, et al.
Publicado: (2023)

Neutralizing and enhancing antibodies against SARS-CoV-2
por: Liu, Yafei, et al.
Publicado: (2022)

Balancing Healthcare and Economy Amidst the COVID-19 Pandemic: An Indian Experience
por: Dhar, Ruby, et al.
Publicado: (2021)

Antibody-Dependent Enhancement: ″Evil″ Antibodies Favorable for Viral Infections
por: Yang, Xiaoke, et al.
Publicado: (2022)

Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway
por: Mielke, Dieter, et al.
Publicado: (2019)

Perspectives on the development of neutralizing antibodies against SARS-CoV-2
por: Ho, Mitchell
Publicado: (2020)

Defining neutralization and allostery by antibodies against COVID-19 variants
por: Tulsian, Nikhil Kumar, et al.
Publicado: (2023)

A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies
por: Sánchez-Zuno, Gabriela Athziri, et al.
Publicado: (2021)

COVID-19 vaccines: neutralizing antibodies and the alum advantage
por: Hotez, Peter J., et al.
Publicado: (2020)

Letter to the editor: Neutralizing antibodies for the treatment of COVID-19
por: Zhou, Zeqi, et al.
Publicado: (2021)

Editorial: Neutralizing Antibodies in the Prevention and Treatment of COVID-19
por: Razonable, Raymund R., et al.
Publicado: (2022)

Neutralization-Enhancing RF Antibodies for HIV Vaccines
por: Suslov, Konstantin V.
Publicado: (2014)

SARS-CoV-2 monoclonal antibodies with therapeutic potential: Broad neutralizing activity and No evidence of antibody-dependent enhancement
por: Wang, Ying-Ting, et al.
Publicado: (2021)

Neutralizing Antibodies Protect against Oral Transmission of Lymphocryptovirus
por: Singh, Swati, et al.
Publicado: (2020)

The “less-is-more” in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity
por: Pereira, Natasha A., et al.
Publicado: (2018)

COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn
por: Munoz, Flor M., et al.
Publicado: (2023)

Status and Developing Strategies for Neutralizing Monoclonal Antibody Therapy in the Omicron Era of COVID-19
por: Ren, Zuning, et al.
Publicado: (2023)

Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
por: Zhou, Guangyu, et al.
Publicado: (2020)

Antibody-dependent enhancement and COVID-19: Moving toward acquittal
por: Yager, Eric J.
Publicado: (2020)

Monoclonal antibody analysis of Porcine Reproductive and Respiratory Syndrome virus epitopes associated with antibody-dependent enhancement and neutralization of virus infection
por: Cancel-Tirado, Sol M., et al.
Publicado: (2004)

Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection
por: Mu, Song, et al.
Publicado: (2022)

Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
por: Landais, Elise, et al.
Publicado: (2018)

COVID-19 neutralizing antibodies predict disease severity and survival
por: Garcia-Beltran, Wilfredo F., et al.
Publicado: (2020)

Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
por: Suthar, Mehul S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h4lgo44ap8gntlaa53rjr635fn